Combining stereotactic radiosurgery and systemic therapy for brain metastases: A potential role for temozolomide

Frontiers in Oncology

Volumn 2 AUG, Issue , 2012, Pages

  Hardee, Matthew E ^a   Formenti, Silvia C ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain metastases; Radiosurgery; Temozolomide

Indexed keywords

CAPECITABINE; CISPLATIN; METHYL CPG BINDING PROTEIN 2; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NAVELBINE; TEMOZOLOMIDE;

ALOPECIA; ARTICLE; ATAXIA; BEHAVIOR CHANGE; BLOOD BRAIN BARRIER; BRAIN METASTASIS; CONSTIPATION; DNA METHYLATION; ERYTHEMA; EXTERNAL OTITIS; FATIGUE; GRANULOCYTOPENIA; HEADACHE; HEARING IMPAIRMENT; HUMAN; HYPOPITUITARISM; LEUKOENCEPHALOPATHY; NAUSEA; NAUSEA AND VOMITING; OVERALL SURVIVAL; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); SOMNOLENCE; STEREOTACTIC RADIOSURGERY; TATA BOX; THROMBOCYTOPENIA; TREATMENT RESPONSE;

EID: 84887618276     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2012.00099     Document Type: Article

References (58)

1. American Cancer Society. (2011). Cancer Facts, and Figures 2011. Available online at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-029771.pdf
2. Abrey, L. E., Olson, J. D., Raizer, J. J., Mack, M., Rodavitch, A., Boutros, D. Y., and Malkin, M. G. (2001). A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J. Neurooncol. 53, 259-265.
3. Addeo, R., Caraglia, M., Faiola, V., Capasso, E., Vincenzi, B., Montella, L., Guarrasi, R., Caserta, L., and Del Prete, S. (2007). Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life. BMC Cancer 7, 18.
4. Addeo, R., De Rosa, C., Faiola, V., Leo, L., Cennamo, G., Montella, L., Guarrasi, R., Vincenzi, B., Caraglia, M., and Del Prete, S. (2008). Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases. Cancer 113, 2524-2531.
5. Adonizio, C. S., Babb, J. S., Maiale, C., Huang, C., Donahue, J., Millenson, M. M., Hosford, M., Somer, R., Treat, J., Sherman, E., and Langer, C. J. (2002). Temozolomide in non-small-cell lung cancer: preliminary results of a phase II trial in previously treated patients. Clin. Lung Cancer 3, 254-258.
6. Andrews, D. W., Scott, C. B., Sperduto, P. W., Flanders, A. E., Gaspar, L. E., Schell, M. C., Werner-Wasik, M., Demas, W., Ryu, J., Bahary, J. P., Souhami, L., Rotman, M., Mehta, M. P., and Curran, W. J. Jr. (2004). Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG (9508). randomised trial. Lancet 363, 1665-1672.
7. Antonadou, D., Paraskevaidis, M., Sarris, G., Coliarakis, N., Economou, I., Karageorgis, P., and Throuvalas, N. (2002). Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J. Clin. Oncol. 20, 3644-3650.
8. Aoyama, H., Shirato, H., Tago, M., Nakagawa, K., Toyoda, T., Hatano, K., Kenjyo, M., Oya, N., Hirota, S., Shioura, H., Kunieda, E., Inomata, T., Hayakawa, K., Katoh, N., and Kobashi, G. (2006). Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295, 2483-2491.
9. Bhatnagar, A. K., Flickinger, J. C., Kondziolka, D., and Lunsford, L. D. (2006). Stereotactic radiosurgery for four or more intracranial metastases. Int. J. Radiat. Oncol. Biol. Phys. 64, 898-903.
10. Chang, E. L., Wefel, J. S., Hess, K. R., Allen, P. K., Lang, F. F., Kornguth, D. G., Arbuckle, R. B., Swint, J. M., Shiu, A. S., Maor, M. H., and Meyers, C. A. (2009). Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 10, 1037-1044.
11. Chang, W. S., Kim, H. Y., Chang, J. W., Park, Y. G., and Chang, J. H. (2010). Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases? J. Neurosurg. 113(Suppl.), 73-78.
12. Chitapanarux, I., Goss, B., Vongtama, R., Frighetto, L., De Salles, A., Selch, M., Duick, M., Solberg, T., Wallace, R., Cabatan-Awang, C., and Ford, J. (2003). Prospective study of stereotactic radiosurgery without whole brain radiotherapy in patients with four or less brain metastases: incidence of intracranial progression and salvage radiotherapy. J. Neurooncol. 61, 143-149.
13. Choong, N. W., Mauer, A. M., Hoffman, P. C., Rudin, C. M., Winegarden, J. D. 3rd, Villano, J. L., Kozloff, M., Wade, J. L. 3rd, Sciortino, D. F., Szeto, L., and Vokes, E. E. (2006). Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer. J. Thorac. Oncol. 1, 245-251.
14. Christodoulou, C., Bafaloukos, D., Kosmidis, P., Samantas, E., Bamias, A., Papakostas, P., Karabelis, A., Bacoyiannis, C., and Skarlos, D. V. (2001). Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Ann. Oncol. 12, 249-254.
15. Christodoulou, C., Bafaloukos, D., Linardou, H., Aravantinos, G., Bamias, A., Carina, M., Klouvas, G., and Skarlos, D. (2005). Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study. J. Neurooncol. 71, 61-65.
16. Danson, S. J., and Middleton, M. R. (2001). Temozolomide: a novel oral alkylating agent. Expert Rev. Anticancer Ther. 1, 13-19.
17. Elliott, R. E., Rush, S. C., Morsi, A., Mehta, N., Spriet, J., Narayana, A., Donahue, B., Parker, E. C., and Golfinos, J. G. (2011). Local control of newly diagnosed and distally recurrent, low-volume brain metastases with fixed-dose (20 gy) gamma knife radiosurgery. Neurosurgery 68, 921-931. discussion: 931.
18. Flickinger, J. C., Kondziolka, D., Lunsford, L. D., Coffey, R. J., Goodman, M. L., Shaw, E. G., Hudgins, W. R., Weiner, R., Harsh, G. R., Sneed, P. K., and Larson, D. A. (1994). A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int. J. Radiat. Oncol. Biol. Phys. 28, 797-802.
19. Gaspar, L., Scott, C., Rotman, M., Asbell, S., Phillips, T., Wasserman, T., McKenna, W. G., and Byhardt, R. (1997). Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int. J. Radiat. Oncol. Biol. Phys. 37, 745-751.
20. Gerosa, M., Nicolato, A., Foroni, R., Zanotti, B., Tomazzoli, L., Miscusi, M., Alessandrini, F., and Bricolo, A. (2002). Gamma knife radiosurgery for brain metastases: a primary therapeutic option. J. Neurosurg. 97, 515-524.
21. Goodhead, D. T. (1994). Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int. J. Radiat. Biol. 65, 7-17.
22. Gril, B., Palmieri, D., Bronder, J. L., Herring, J. M., Vega-Valle, E., Feigenbaum, L., Liewehr, D. J., Steinberg, S. M., Merino, M. J., Rubin, S. D., and Steeg, P. S. (2008). Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J. Natl. Cancer Inst. 100, 1092-1103.
23. Gril, B., Evans, L., Palmieri, D., and Steeg, P. S. (2010). Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies. Eur. J. Cancer 46, 1204-1210.
24. Gril, B., Palmieri, D., Qian, Y., Smart, D., Ileva, L., Liewehr, D. J., Steinberg, S. M., and Steeg, P. S. (2011). Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis. Clin. Cancer Res. 17, 142-153.
25. Hasegawa, T., Kondziolka, D., Flickinger, J. C., Germanwala, A., and Lunsford, L. D. (2003). Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy? Neurosurgery 52, 1318-1326. discussion: 1326.
26. Hegi, M. E., Diserens, A. C., Gorlia, T., Hamou, M. F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., Bromberg, J. E., Hau, P., Mirimanoff, R. O., Cairncross, J. G., Janzer, R. C., and Stupp, R. (2005). MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352, 997-1003.
27. Iwamoto, F. M., Omuro, A. M., Raizer, J. J., Nolan, C. P., Hormigo, A., Lassman, A. B., Gavrilovic, I. T., and Abrey, L. E. (2008). A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases. J. Neurooncol. 87, 85-90.
28. Kihlstrom, L., Karlsson, B., and Lindquist, C. (1993). Gamma Knife surgery for cerebral metastases. Implications for survival based on 16 years experience. Stereotact. Funct. Neurosurg. 61(Suppl. 1), 45-50.
29. Kondziolka, D., Patel, A., Lunsford, L. D., Kassam, A., and Flickinger, J. C. (1999). Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 45, 427-434.
30. Kouvaris, J. R., Miliadou, A., Kouloulias, V. E., Kolokouris, D., Balafouta, M. J., Papacharalampous, X. N., and Vlahos, L. J. (2007). Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors. Onkologie 30, 361-366.
31. Lee, Y. K., Park, N. H., Kim, J. W., Song, Y. S., Kang, S. B., and Lee, H. P. (2008). Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer. Gynecol. Oncol. 108, 505-509.
32. Lens, M. B., and Eisen, T. G. (2003). Systemic chemotherapy in the treatment of malignant melanoma. Expert Opin. Pharmacother. 4, 2205-2211.
33. Lutterbach, J., Cyron, D., Henne, K., and Ostertag, C. B. (2003). Radiosurgery followed by planned observation in patients with one to three brain metastases. Neurosurgery 52, 1066-1073. discussion: 1073-1074.
34. Margolin, K., Atkins, B., Thompson, A., Ernstoff, S., Weber, J., Flaherty, L., Clark, I., Weiss, G., Sosman, J., II Smith, W. Dutcher, P., Gollob, J., Longmate, J., and Johnson, D. (2002). Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group. J. Cancer Res. Clin. Oncol. 128, 214-218.
35. Mikkelsen, T., Anderson, J., Doyle, T. J., Croteau, D., Avedissian, R., Ryu, S., and Schultz, L. (2010). Phase I/II dose escalation trial of concurrent temozolomide and whole brain radiation therapy for multiple brain metastasis. J. Neurooncol. 100, 241-247.
36. Nakagawachi, T., Soejima, H., Urano, T., Zhao, W., Higashimoto, K., Satoh, Y., Matsukura, S., Kudo, S., Kitajima, Y., Harada, H., Furukawa, K., Matsuzaki, H., Emi, M., Nakabeppu, Y., Miyazaki, K., Sekiguchi, M., and Mukai, T. (2003). Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Oncogene 22, 8835-8844.
37. Omuro, A. M., Raizer, J. J., Demopoulos, A., Malkin, M. G., and Abrey, L. E. (2006). Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial. J. Neurooncol. 78, 277-280.
38. Palmieri, D., Lockman, P. R., Thomas, F. C., Hua, E., Herring, J., Hargrave, E., Johnson, M., Flores, N., Qian, Y., Vega-Valle, E., Taskar, K. S., Rudraraju, V., Mittapalli, R. K., Gaasch, J. A., Bohn, K. A., Thorsheim, H. R., Liewehr, D. J., Davis, S., Reilly, J. F., Walker, R., Bronder, J. L., Feigenbaum, L., Steinberg, S. M., Camphausen, K., Meltzer, P. S., Richon, V. M., Smith, Q. R., and Steeg, P. S. (2009). Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks. Clin. Cancer Res. 15, 6148-6157.
39. Patchell, R. A. (2003). The management of brain metastases. Cancer Treat. Rev. 29, 533-540.
40. Pegg, A. E. (2000). Repair of O(6)-alkylguanine by alkyltransferases. Mutat. Res. 462, 83-100.
41. Petrovich, Z., Yu, C., Giannotta, S. L., O'Day, S., and Apuzzo, M. L. (2002). Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J. Neurosurg. 97, 499-506.
42. Qian, Y., Hua, E., Bisht, K., Woditschka, S., Skordos, K. W., Liewehr, D. J., Steinberg, S. M., Brogi, E., Akram, M. M., Killian, J. K., Edelman, D. C., Pineda, M., Scurci, S., Degenhardt, Y. Y., Laquerre, S., Lampkin, T. A., Meltzer, P. S., Camphausen, K., Steeg, P. S., and Palmieri, D. (2011). Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain. Clin. Exp. Metastasis 28, 899-908.
43. Rivera, E., Meyers, C., Groves, M., Valero, V., Francis, D., Arun, B., Broglio, K., Yin, G., Hortobagyi, G. N., and Buchholz, T. (2006). Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer 107, 1348-1354.
44. Robins, H. I., Traynor, A. M., and Mehta, M. (2006). Temozolomide as prophylaxis for brain metastasis in non-small cell lung cancer. J. Thorac. Oncol. 1, 732-733. Author reply: 733.
45. Schadendorf, D., Hauschild, A., Ugurel, S., Thoelke, A., Egberts, F., Kreissig, M., Linse, R., Trefzer, U., Vogt, T., Tilgen, W., Mohr, P., and Garbe, C. (2006). Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study. Ann. Oncol. 17, 1592-1597.
46. Siena, S., Crino, L., Danova, M., Del Prete, S., Cascinu, S., Salvagni, S., Schiavetto, I., Vitali, M., and Bajetta, E. (2010). Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study. Ann. Oncol. 21, 655-661.
47. Sperduto, P. W., Berkey, B., Gaspar, L. E., Mehta, M., and Curran, W. (2008). A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int. J. Radiat. Oncol. Biol. Phys. 70, 510-514.
48. Steeg, P. S., Camphausen, K. A., and Smith, Q. R. (2011). Brain metastases as preventive and therapeutic targets. Nat. Rev. Cancer 11, 352-363.
49. Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., Hau, P., Brandes, A. A., Gijtenbeek, J., Marosi, C., Vecht, C. J., Mokhtari, K., Wesseling, P., Villa, S., Eisenhauer, E., Gorlia, T., Weller, M., Lacombe, D., Cairncross, J. G., and Mirimanoff, R. O. (2009). Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10, 459-466.
50. Suh, J. H. (2010). Stereotactic radiosurgery for the management of brain metastases. N. Engl. J. Med. 362, 1119-1127.
51. Suzuki, S., Omagari, J., Nishio, S., Nishiye, E., and Fukui, M. (2000). Gamma knife radiosurgery for simultaneous multiple metastatic brain tumors. J. Neurosurg. 93(Suppl. 3), 30-31.
52. Tannehill, S. P., Mehta, M. P., Larson, M., Storer, B., Pellet, J., Kinsella, T. J., and Schiller, J. H. (1997). Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial. J. Clin. Oncol. 15, 2850-2857.
53. Tsao, M. N., Rades, D., Wirth, A., Lo, S. S., Danielson, B. L., Gaspar, L. E., Sperduto, P. W., Vogelbaum, M. A., Radawski, J. D., Wang, J. Z., Gillin, M. T., Mohideen, N., Hahn, C. A., and Chang, E. L. (2012). Radiotherapeutic and surgical management for newly diagnosed brain metastasis (es): An American Society for Radiation Oncology evidence-based guideline. Pract. Radiat. Oncol. 2, 210-225.
54. Verger, E., Gil, M., Yaya, R., Vinolas, N., Villa, S., Pujol, T., Quinto, L., and Graus, F. (2005). Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 61, 185-191.
55. Weller, M., Stupp, R., Reifenberger, G., Brandes, A. A., van den Bent, M. J., Wick, W., and Hegi, M. E. (2010). MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat. Rev. Neurol. 6, 39-51.
56. Williams, B. J., Suki, D., Fox, B. D., Pelloski, C. E., Maldaun, M. V., Sawaya, R. E., Lang, F. F., and Rao, G. (2009). Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J. Neurosurg. 111, 439-448.
57. Wu, P. F., Kuo, K. T., Kuo, L. T., Lin, Y. T., Lee, W. C., Lu, Y. S., Yang, C. H., Wu, R. M., Tu, Y. K., Tasi, J. C., Tseng, H. M., Tseng, S. H., Cheng, A. L., and Lin, C. H. (2010). O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers. Lung Cancer 68, 484-490.
58. Yamamoto, M., Ide, M., Nishio, S., and Urakawa, Y. (2002). Gamma Knife radiosurgery for numerous brain metastases: is this a safe treatment? Int. J. Radiat. Oncol. Biol. Phys. 53, 1279-1283.